MIRA Pharmaceuticals, Inc. (MIRA)

USD 1.05

(-1.87%)

Total Debt Summary of MIRA Pharmaceuticals, Inc.

MIRA Pharmaceuticals, Inc.'s latest annual total debt in 2023 was 5061.00 USD , down -98.97% from previous year.
MIRA Pharmaceuticals, Inc.'s latest quarterly total debt in 2024 Q2 was - USD , down -100.0% from previous quarter.
MIRA Pharmaceuticals, Inc. reported annual total debt of 491.23 Thousand USD in 2022, up 67.62% from previous year.
MIRA Pharmaceuticals, Inc. reported annual total debt of 293.06 Thousand USD in 2021, up 225.62% from previous year.
MIRA Pharmaceuticals, Inc. reported quarterly total debt of - USD for 2024 Q2, down -100.0% from previous quarter.
MIRA Pharmaceuticals, Inc. reported quarterly total debt of 5061.00 USD for 2023 FY, down -98.97% from previous quarter.

Annual Total Debt Chart of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Historical Annual Total Debt of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Year	Total Debt	Total Debt Growth
2023	5061.00 USD	-98.97%
2022	491.23 Thousand USD	67.62%
2021	293.06 Thousand USD	225.62%
2020	90 Thousand USD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	1273.00 USD	-74.85%
2024 Q2	- USD	-100.0%
2023 FY	5061.00 USD	-98.97%
2023 Q2	1.92 Million USD	435.23%
2023 Q1	360.55 Thousand USD	-26.6%
2023 Q4	5061.00 USD	-95.35%
2023 Q3	108.85 Thousand USD	-94.36%
2022 Q4	491.23 Thousand USD	0.0%
2022 FY	491.23 Thousand USD	67.62%
2022 Q3	- USD	0.0%
2022 Q1	431.75 Thousand USD	0.0%
2021 Q1	- USD	0.0%
2021 FY	293.06 Thousand USD	225.62%
2020 FY	90 Thousand USD	0.0%

Peer Total Debt Comparison of MIRA Pharmaceuticals, Inc.

Name	Total Debt	Total Debt Difference
Amgen Inc.	64.61 Billion USD	100.0%
AstraZeneca PLC	28.62 Billion USD	100.0%
Biogen Inc.	7.33 Billion USD	100.0%
Gilead Sciences, Inc.	24.98 Billion USD	100.0%
Scilex Holding Company	128.46 Million USD	99.996%
Scilex Holding Company	128.46 Million USD	99.996%